3045 results found
The Advisory Committee for Research into Debilitating Symptoms Complexes Attributed to Ticks (DSCATT) was established to define the context, objectives and desired research outcomes of the Targeted Call for Research (TCR) into DSCATT. Their knowledge and experience provided the contextual information to ensure the TCR into DSCATT made best use of the available research funds. The Advisory Committee included a range of scientific experts including infectious disease physicians and a consumer representative.
NHMRC has rigorous standards in place to ensure that guidelines and advice are high quality and based on the best available scientific evidence.
There are many steps involved when developing guidelines with engagement from a variety of different stakeholders. They are developed by multidisciplinary committees that follow a rigorous evidence-based approach. They are informed by the judgement of evidence by experts, and the views of consumers, community groups and other people affected by the guidelines.
To support the development of the highest quality guidelines and advice, NHMRC has robust processes in place to manage conflict of interest and to use recognised tools to assess the evidence for quality and bias.
The Principles are high-level, guiding statements, that underpin NHMRC's peer review processes and will apply to all NHMRC funding schemes.
NHMRC offers a range of funding pathways, depending on your objectives, funding amount, timeframes and other preferences. The Partnering Decision Tree below presents potential partners with options to assist in making a decision on the type of funding model to adopt.
The major national health issues outlined below are NHMRC's health priorities for the 2024–2027 triennium.
On 15 November 2022, the National Health and Medical Research Council (NHMRC) co-hosted an online workshop with the CHF to commence the review of the Statement on Consumer and Community Involvement in Health and Medical Research (2016) (the Statement). See also consumer and community engagement
Within the framework of the Corporate Plan, the National Health and Medical Research Council (NHMRC) has established a strategy to guide new and existing activities with our international partners.
The NHMRC and ARC Statement on Open Researcher and Contributor ID explains NHMRC's position on the ORCID researcher identifier.
The Statement on consumer and community involvement in health and medical research (The Statement), co-authored by the National Health and Medical Research Council (NHMRC) and the Consumers Health Forum of Australia (CHF), aims to guide research institutions, researchers, consumers and community members in the active involvement of consumers and community members in all aspects of health and medical research.
The Australian Government's Boosting Dementia Research Initiative invested $200 million over 5 years from 2014 to 2019 to accelerate research, enhance collaboration and promote advances in dementia research and treatment. The Boosting Dementia Research Initiative (BDRI) consisted of two main elements: